Frontiers in Cardiovascular Medicine
Ultra-early in-cath lab evolocumab achieves rapid lipid target attainment and lipid quality improvement in acute coronary syndrome: a real-world propensity score-matched study
Study in peopleInterventions
Papers by Pujiao Yu
1 result